DK0912195T3 - Vaccine indeholdende antigener bundet til bærestoffer gennem labile bindinger - Google Patents
Vaccine indeholdende antigener bundet til bærestoffer gennem labile bindingerInfo
- Publication number
- DK0912195T3 DK0912195T3 DK97927484T DK97927484T DK0912195T3 DK 0912195 T3 DK0912195 T3 DK 0912195T3 DK 97927484 T DK97927484 T DK 97927484T DK 97927484 T DK97927484 T DK 97927484T DK 0912195 T3 DK0912195 T3 DK 0912195T3
- Authority
- DK
- Denmark
- Prior art keywords
- antigen
- carriers
- preparations
- vaccine containing
- labile
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6018—Lipids, e.g. in lipopeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14311—Parvovirus, e.g. minute virus of mice
- C12N2750/14322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Communicable Diseases (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96201766 | 1996-06-25 | ||
PCT/NL1997/000354 WO1997049425A1 (en) | 1996-06-25 | 1997-06-24 | Vaccine comprising antigens bound to carriers through labile bonds |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0912195T3 true DK0912195T3 (da) | 2009-05-18 |
Family
ID=8224113
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK97927484T DK0912195T3 (da) | 1996-06-25 | 1997-06-24 | Vaccine indeholdende antigener bundet til bærestoffer gennem labile bindinger |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0912195B1 (da) |
JP (1) | JP4651753B2 (da) |
AT (1) | ATE421331T1 (da) |
AU (1) | AU732085B2 (da) |
BR (1) | BR9709993A (da) |
CA (1) | CA2260761C (da) |
DE (1) | DE69739233D1 (da) |
DK (1) | DK0912195T3 (da) |
NZ (1) | NZ333562A (da) |
WO (1) | WO1997049425A1 (da) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6846968B1 (en) | 1988-02-26 | 2005-01-25 | Large Scale Biology Corporation | Production of lysosomal enzymes in plants by transient expression |
US5907030A (en) | 1995-01-25 | 1999-05-25 | University Of Southern California | Method and compositions for lipidization of hydrophilic molecules |
CN1127477C (zh) * | 1996-09-26 | 2003-11-12 | 南加利福尼亚大学 | 用于亲水分子脂质化的方法和组合物 |
GB9915074D0 (en) * | 1999-06-28 | 1999-08-25 | Cortecs Plc | Ligand-binding composition |
US6730306B1 (en) | 2000-03-08 | 2004-05-04 | Large Scale Biology Corporation | Parvovirus vaccine as viral coat protein fusions |
EP2011517A1 (en) | 2001-04-04 | 2009-01-07 | Nordic Vaccine Technology A/S | Polynucleotide binding complexes comprising sterols and saponin |
WO2004000217A2 (en) * | 2002-06-20 | 2003-12-31 | The Trustees Of The University Of Pennsylvania | Vaccines for suppressing ige-mediated allergic disease and methods for using the same |
EP2358739A1 (en) * | 2008-11-18 | 2011-08-24 | The University Of Queensland | Peptide conjugates for suppressing an immune response, methods of making and uses therefor |
WO2011123042A1 (en) * | 2010-04-01 | 2011-10-06 | Independent Pharmaceutica Ab | Vaccination procedure and products for use therein |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3937412A1 (de) * | 1989-11-10 | 1991-05-16 | Hoechst Ag | Synthetische vakzine zur spezifischen induktion zytotoxischer t-lymphozyten |
NL8900726A (nl) * | 1989-03-23 | 1990-10-16 | Stichting Centr Diergeneeskund | Peptide, immunogene samenstelling en vaccin- of geneesmiddelpreparaat; werkwijze voor het immuniseren van een zoogdier tegen lhrh, en werkwijze voor het verbeteren van de vleeskwaliteit van varkens. |
US5256641A (en) | 1990-11-01 | 1993-10-26 | State Of Oregon | Covalent polar lipid-peptide conjugates for immunological targeting |
EP0491077A1 (en) * | 1990-12-19 | 1992-06-24 | Medeva Holdings B.V. | A composition used as a therapeutic agent against chronic viral hepatic diseases |
DE4101394A1 (de) * | 1991-01-18 | 1992-07-23 | Medor Lab Fuer Biochemie Und K | Verfahren zum koppeln von kohlenhydraten an traeger, insbesondere proteine |
EP0596959B1 (en) * | 1991-07-26 | 2000-03-29 | Commonwealth Scientific And Industrial Research Organisation | Self-adjuvanting peptide vaccine delivery system and production thereof |
DK0647655T3 (da) * | 1993-01-23 | 1999-08-23 | Inmunologia & Genetica Aplic | Syntetiske peptider og vacciner mod parvovirus |
DK0708656T3 (da) * | 1993-04-27 | 2002-12-02 | United Biomedical Inc | Antigene LHRH peptidkonstruktioner og universelle syntetiske immunstimulatorer til vacciner |
NZ274376A (en) | 1993-09-22 | 1997-11-24 | Jackson H M Found Military Med | Activating soluble carbohydrate using cyanylating reagents for the production of immunogenic constructs |
-
1997
- 1997-06-24 AU AU31938/97A patent/AU732085B2/en not_active Ceased
- 1997-06-24 CA CA2260761A patent/CA2260761C/en not_active Expired - Fee Related
- 1997-06-24 NZ NZ333562A patent/NZ333562A/en not_active IP Right Cessation
- 1997-06-24 WO PCT/NL1997/000354 patent/WO1997049425A1/en active Application Filing
- 1997-06-24 BR BR9709993A patent/BR9709993A/pt not_active Application Discontinuation
- 1997-06-24 DK DK97927484T patent/DK0912195T3/da active
- 1997-06-24 AT AT97927484T patent/ATE421331T1/de active
- 1997-06-24 JP JP50272998A patent/JP4651753B2/ja not_active Expired - Fee Related
- 1997-06-24 EP EP97927484A patent/EP0912195B1/en not_active Expired - Lifetime
- 1997-06-24 DE DE69739233T patent/DE69739233D1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU732085B2 (en) | 2001-04-12 |
BR9709993A (pt) | 1999-08-10 |
WO1997049425A1 (en) | 1997-12-31 |
EP0912195A1 (en) | 1999-05-06 |
JP2000513353A (ja) | 2000-10-10 |
NZ333562A (en) | 2001-04-27 |
ATE421331T1 (de) | 2009-02-15 |
JP4651753B2 (ja) | 2011-03-16 |
DE69739233D1 (de) | 2009-03-12 |
EP0912195B1 (en) | 2009-01-21 |
CA2260761C (en) | 2011-05-03 |
AU3193897A (en) | 1998-01-14 |
CA2260761A1 (en) | 1997-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1995029193A3 (en) | Melanoma antigens | |
RU2002104700A (ru) | Слитые белки с Fc-фрагментом иммуноглобулина для повышения иммуногенности белковых и пептидных антигенов | |
CA2378866A1 (en) | Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens | |
RU95105991A (ru) | Конъюгат, вакцина, способы усиления иммуногенности, способы иммунизации | |
DK0912195T3 (da) | Vaccine indeholdende antigener bundet til bærestoffer gennem labile bindinger | |
CA2912496C (en) | Immunogenic composition for use in therapy | |
WO2005007673A3 (en) | Immunogenic peptides | |
DE69534382D1 (de) | Peptide, verwendet als träger in immunogenen konstrukten, die in der entwicklung synthetischer impfstoffe geeignet sind | |
ATE370745T1 (de) | Verbesserte polysaccharid- und glykokonjugat- vakzine | |
EP1124576A2 (en) | Method for preparing solid phase conjugate vaccines | |
Rauly et al. | Carrier properties of a protein derived from outer membrane protein A of Klebsiella pneumoniae | |
NZ500151A (en) | A general method for attaching DNA molecule comprising non-antibody target molecule (eg. CTLA-4 or L-selectin), antigen or epitope sequence, and optionally a polypeptide sequence | |
Coughlin et al. | Adjuvant activity of QS-21 for experimental E. coli 018 polysaccharide vaccines | |
AU4803785A (en) | Cross-reactive and protective epitopes of circumsporozoite proteins | |
US8153135B2 (en) | Polysaccharide-polypeptide conjugate | |
DK1035133T3 (da) | Fusionsproteiner, der omfatter bærere, som kan inducere et dobbelt immunrespons | |
WO2001085763A3 (en) | Chimeric peptide immunogens their preparation and use | |
Raya et al. | A prime-boost regime that combines Montanide ISA720 and Alhydrogel to induce antibodies against the HIV-1 derived multiepitope polypeptide TAB9 | |
Skea et al. | Adhesion-mediated enhancement of the adjuvant activity of alum | |
CA2404111C (en) | A polysaccharide-polypeptide conjugate | |
DE60016806D1 (de) | Selfantigen-impfstoffe zur behandlung von b-zell lymphomen und sonstigen krebsen | |
BR9905780A (pt) | Antìgenos vacinais de leptospira para prevenção da laptospirose | |
Lovgren | Construction and potential of the iscom as immunogen. | |
DE69322960D1 (de) | Empfängnisverhütender impfstoff | |
Opuda-Asibo | Expression of humoral immunologic mechanisms against Pasteurella haemolytica in the bovine lung. |